Clinical trial focus Position Syntropic CoreLab as a specialized partner for comprehensive core lab support across vascular-focused trials, leveraging expertise in carotid, renal, iliac, femoro-popliteal, infra-popliteal arteries, aorta, pulmonary arteries, and venous systems to streamline trial staging and data quality.

Mid-market growth Target mid-sized hospitals and health systems in the U.S. with 50 or fewer employees that run or plan vascular clinical trials, emphasizing flexible services, scalable core lab and educational offerings, and cost-effective trial management.

Digital footprint Leverage Squarespace and Microsoft 365 as scalable platforms to enhance online presence, client portals, and collaboration tools for investigators, sites, and sponsors, highlighting efficiency and secure communications.

Research alignment Align outreach with similar companies in the space by benchmarking services against modest revenue bands and emphasize differentiators such as specialized vascular core lab capabilities to win projects from larger CROs or academic centers.

Financial readiness Highlight lean, service-focused revenue model with a stated $1M-$10M revenue range to engage sponsors seeking cost-effective core lab support, offering flexible pricing, risk-sharing options, and fast onboarding for vascular trial programs.